A

Amyl Therapeutics

6 employees

Amyl Therapeutics is a preclinical stage biotechnology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
amyloidosis
Medical
Alzheimer
Parkinson
Life Science
Biopharmaceutical research

Date founded

2020

Funding rounds raised

Total raised

$10M

from 2 investors over 2 rounds

A

Amyl Therapeutics raised $10M on June 3, 2021

Investors: - and Smedvig Eiendom

FAQ